Victoria L.M. Herrera, MD

Professor, Medicine

617.638.4020
700 Albany St Ctr for Adv Biomed Res

Biography

Expertise includes: Transgenic Rat model development and analysis; Ultrasound Micro-Imaging; Ultrasound Contrast-enhanced Molecular Imaging; Ultrasound-Enhanced Gene Transfer; Nanotheranostics.

Other Positions

  • Center Faculty Member, Cardiovascular Institute (Whitaker), Boston University School of Medicine
  • Graduate Faculty (Primary Mentor of Grad Students), Boston University School of Medicine, Graduate Medical Sciences

Education

  • University of the Philippines, MD
  • University of the Philippines, BS

Publications

  • Published on 9/11/2018

    Herrera VL, Colby AH, Ruiz-Opazo N, Coleman DG, Grinstaff MW. Nucleic acid nanomedicines in Phase II/III clinical trials: translation of nucleic acid therapies for reprogramming cells. Nanomedicine (Lond). 2018 08; 13(16):2083-2098. PMID: 30204054.

    Read at: PubMed
  • Published on 2/9/2017

    Colby AH, Oberlies NH, Pearce CJ, Herrera VL, Colson YL, Grinstaff MW. Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 May; 9(3). PMID: 28185434.

    Read at: PubMed
  • Published on 2/1/2017

    Colby AH, Berry SM, Moran AM, Pasion KA, Liu R, Colson YL, Ruiz-Opazo N, Grinstaff MW, Herrera VL. Highly Specific and Sensitive Fluorescent Nanoprobes for Image-Guided Resection of Sub-Millimeter Peritoneal Tumors. ACS Nano. 2017 02 28; 11(2):1466-1477. PMID: 28099801.

    Read at: PubMed
  • Published on 1/1/2017

    Colby AH, Oberlies NH, Pearce CJ, Herrera V, Colson YL, Grinstaff M. Cover Image, Volume 9, Issue 3. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 2017; 9(3):e1474.

    Read at: Custom
  • Published on 1/1/2017

    Colby AH, Oberlies NH, Pearce C, Herrera V, Colson YL, Grinstaff M. Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle: Nanoparticle drug-delivery systems for peritoneal cancers. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 2017; 9(3):e1451.

    Read at: Custom
  • Published on 11/11/2016

    Matsuura S, Patterson S, Lucero H, Leiva O, Grant AK, Herrera VL, Ravid K. In vivo magnetic resonance imaging of a mouse model of myelofibrosis. Blood Cancer J. 2016 11 11; 6(11):e497. PMID: 27834941.

    Read at: PubMed
  • Published on 6/14/2016

    Herrera VL, Steffen M, Moran AM, Tan GA, Pasion KA, Rivera K, Pappin DJ, Ruiz-Opazo N. Confirmation of translatability and functionality certifies the dual endothelin1/VEGFsp receptor (DEspR) protein. BMC Mol Biol. 2016 Jun 14; 17(1):15. PMID: 27301377.

    Read at: PubMed
  • Published on 4/14/2016

    Herrera VL, Colby AH, Tan GA, Moran AM, O'Brien MJ, Colson YL, Ruiz-Opazo N, Grinstaff MW. Evaluation of expansile nanoparticle tumor localization and efficacy in a cancer stem cell-derived model of pancreatic peritoneal carcinomatosis. Nanomedicine (Lond). 2016 May; 11(9):1001-15. PMID: 27078118.

    Read at: PubMed
  • Published on 1/11/2016

    Decano JL, Pasion KA, Black N, Giordano NJ, Herrera VL, Ruiz-Opazo N. Sex-specific genetic determinants for arterial stiffness in Dahl salt-sensitive hypertensive rats. BMC Genet. 2016; 17:19. PMID: 26754450.

    Read at: PubMed
  • Published on 7/6/2015

    Falde EJ, Freedman JD, Herrera VL, Yohe ST, Colson YL, Grinstaff MW. Layered superhydrophobic meshes for controlled drug release. J Control Release. 2015 Sep 28; 214:23-9. PMID: 26160309.

    Read at: PubMed

View 83 more publications: View full profile at BUMC

View all profiles